Cathepsin D expression in chronic plaque psoriasis: An immunohistochemical study

Acta Dermatovenerologica Croatica

Volumn 19, Issue 3, 2011, Pages 143-149

  Abdou, Asmaa Gaber ^a   Maraee, Alaa Hassan ^a   Shoeib, Mohamed Abd El Monaem ^a   Elsammie, Abeer Ahmed Abd ^a   Elnaidany, Nada Farag ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b October University for Modern Sciences and Arts   (Egypt)

Author keywords

Cathepsin D; Immunohistochemistry; Proteases; Psoriasis

Indexed keywords

CATHEPSIN D; METHOXSALEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC DISEASE; CHRONIC PSORIASIS VULGARIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; PSORIASIS VULGARIS; PUVA; SCHOOL CHILD; SKIN BIOPSY;

ADOLESCENT; ADULT; AGED; CATHEPSIN D; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PSORIASIS; PUVA THERAPY; SKIN; YOUNG ADULT;

EID: 80052973910     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Stuart P, Malick F, Nair RP, Henseler T, Lim HW, Jenisch S, et al. Analysis of phenotypic variation in psoriasis as a function of age at onset and family history. Arch Dermatol Res 2002;294:207-13.
2. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007;356:580-92.
3. Dickinson DP. Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 2002;13:238-75.
4. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oreic K, et al. Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 2002;383:1035-44.
5. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov 2002;1:727-30.
6. Tang J, Wong RN. Evolution in the structure and function of aspartic proteases. J Cell Biochem 1987;33:53-63.
7. Hsueh WA, Baxter JD. Human prorenin. Hypertension 1991;17:469-77.
8. Sato K, Waguri S, Nitatori T, Kon S, Kominami E, Watanabe T, et al. Immunocytochemical localization of lysosomal cysteine and aspartatic proteinases, and ubiquitin in rat epidermis. Arch Histol Cytol 1997;30:275-87.
9. Kawada A, Hara K, Kominami E, Hiruma M, Noguchi H, Ishibashi A. Processing of cathepsins L, B and D in psoriatic epidermis. Arch Dermatol Res 1997;289:87-93.
10. Horikoshi, T, Igarishi S, Uchiwa H, Brysk H, Brysk MM. Role of endogenous cathepsin D-like and chymotrypsin-like proteolysis in human epidermal desquamation. Br J Dermatol 1999;141:453-9.
11. Serre G, Mils V, Haftek M, Vincent C, Croute F, Réano A, et al. Identification of late differentiation antigens of human cornified epithelia, expressed in reorganized desmosomes and bound to cross-linked envelope. J Invest Dermatol 1991;97:1061-72.
12. Igarashi S, Takizawa T, Takizawa T, Yasuda Y, Uchiwa H, Hayashi S, et al. Cathepsin D, but not cathepsin E, degrades desmosomes during epidermal desquamation. Br J Dermatol 2004;151:355-61.
13. Lazarus, GS, Poole R. Immunocytochemical localization of cathepsin D in rabbit skin. Arch Dermatol 1975;111:1150-3.
14. Horikoshi T, Arany I, Rajaraman S, Chen S-H, Brysk H, Lei G, et al. Isoforms of cathepsin D and human epidermal differentiation. Biochimie (Paris) 1998;80:605-12.
15. Egberts F, Heinrich M, Jensen, JM. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation. J Cell Sci 2004;117:2295-307.
16. Vashishta A, Saraswat Ohri S, Vetvickova J, Fusek M, Ulrichova J, Vetvicka V. Procathepsin D secreted by HaCaT keratinocyte cells - a novel regulator of keratinocyte growth. Eur J Cell Biol 2007;86:303-13.
17. Rice RH, Green H. Presence in human epidermal cells of a soluble protein precursor of the crosslinked envelope: activation of the cross-linking by calcium ions. Cell 1979;18:681-94.
18. Dover R, Watt FM. Measurement of the rate of epidermal terminal differentiation: expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. J Invest Dermatol 1987;89:349-52.
19. Watt FM, Boukamp P, Hornung J, Fusenig NE. Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes. Arch Dermatol Res 1987;279:335-40.
20. Negi M, Matsui T, Ogawa H. Mechanism of human epidermal transglutaminase. J Invest Dermatol 1981;77:389-92.
21. Chen SH, Arany I, Apisarnthanarax N, Rajaraman S, Tyring SK, Horikoshi T, et al. Response of keratinocytes from normal and psoriatic epidermis to interferon- gamma differs in the expression of zincalpha(2)-glycoprotein and cathepsin D. FASEB J 2000;14:565-71.
22. Minarowska A, Gacko M, Karwowska A Minarowski Ł. Human cathepsin D. Folia Histochem Cytobiol 2008;46:23-38.
23. Berchem GJ, Glondu M, Gleizes M, Brouillet JP, Garcia M, Liaudet-Coopman E. Cathepsin-D affects multiple steps of tumor progression: proliferation, angiogenesis and apoptosis. Oncogene 2002;21:5951-5.
24. Abdou AG, Hanout HM. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study. J Cutan Pathol 2008;35:445-51.
25. González-Vela MC, Garijo MF, Fernández F, Buelta L, Val-Bernal JF. Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma. Histopathology 1999;34:35-42.
26. Lösch A, Schindl M, Kohlberger P, Lahodny J, Breitenecker G, Horvat R, et al. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Gynecol Oncol 2004;92:545-52.
27. Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D, et al. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 1991;194:252-9.
28. Piwnica D, Fernandez I, Binart N, Touraine P, Kelly PA, Goffin V. A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. Mol Endocrinol 2006;20:3263-78.
29. Vallat VP, Gilleaudeau P, Battat L, Wolfe J, Nabeya R, Heftler N, et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 1994;180:283-96.